Imidazole → 4-[(Tert-butyldimethylsilyl)oxy]-2-chlorobenzaldehyde
Reaction equation
[Cl:1][C:2]1[CH:9]=[C:8]([OH:10])[CH:7]=[CH:6][C:3]=1[CH:4]=[O:5].[Si:11](Cl)([C:14]([CH3:17])([CH3:16])[CH3:15])([CH3:13])[CH3:12].N1C=CN=C1>CN(C)C=O>[Si:11]([O:10][C:8]1[CH:7]=[CH:6][C:3]([CH:4]=[O:5])=[C:2]([Cl:1])[CH:9]=1)([C:14]([CH3:17])([CH3:16])[CH3:15])([CH3:13])[CH3:12]Participants
Procedure
A solution of 2-chloro-4-hydroxybenzaldehyde (5.0 g, 32 mmol), tert-butyl(dimethyl)silyl chloride (5.3 g, 35 mmol), imidazole (2.9 g, 45 mmol) and N,N-dimethylaminopyridine (10 mg) in N,N-dimethylformamide (40 mL) was stirred at room temperature for 16 hours. The solvent was removed in vacuo and the residue was partitioned between ethyl acetate (100 mL) and water (100 mL). The organic phase was separated, washed with brine (50 mL), dried over sodium sulfate and concentrated in vacuo. Purification by column chromatography on silica gel, eluting with pentane:ethyl acetate, 75:25 to 67:33, afforded the title compound as a colourless oil in 75% yield, 6.50 g. 1HNMR (400 MHz, CDCl3) δ: 0.25 (6H, s), 0.97 (9H, s), 6.80 (1H, dd), 6.87 (1H, d), 7.84 (1H, d), 10.32 (1H, s)
Workup
- customThe solvent was removed in vacuo
- customthe residue was partitioned between ethyl acetate (100 mL) and water (100 mL)
- customThe organic phase was separated
- washwashed with brine (50 mL)
- dry with materialdried over sodium sulfate
- concentrationconcentrated in vacuo
- customPurification by column chromatography on silica gel
- washeluting with pentane
Sources & evidence
- ORD record
- ord-ca0015b9261f445282b2d3b8cc057ac1
- Source dataset
- uspto-grants-2009_06
- Patent number
- US07547731B2
Reaction notes
Loading…